Integrated Wealth Concepts LLC Biomarin Pharmaceutical Inc Transaction History

Integrated Wealth Concepts LLC

  • $7.02 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $1,508 - $1,782
18 Added 0.58%
3,097 $270,000
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $1,981 - $2,561
-26 Reduced 0.84%
3,079 $296,000
Q3 2023

Nov 15, 2023
BUY
$85.07 - $94.48 $52,913 - $58,766
622 Added 25.05%
3,105 $274,000
Q2 2023

Aug 15, 2023
BUY
$86.68 - $100.3 $215,226 - $249,044
2,483 New
2,483 $215,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email